About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

VA-ECMO as a Treatment for Right Heart Catheterisation-related PA Injury

Published:

07 February 2022

Citation:

Cardiac Failure Review 2022;8:e03.

T1 and T2 Mapping in Uremic Cardiomyopathy

Published:

17 January 2022

Citation:

Cardiac Failure Review 2022;8:e02.

Endpoints in Heart Failure Drug Development

Published:

17 January 2022

Citation:

Cardiac Failure Review 2022;8:e01.

Isolated Left Ventricular Apical Hypoplasia

Published:

06 December 2021

Citation:

Cardiac Failure Review 2021;7:e21.